In vivo 13C magnetic resonance spectroscopy of human brain on a clinical 3 T scanner using [2-13C]glucose infusion and low-power stochastic decoupling

Magnetic Resonance in Medicine

Volumn 62, Issue 3, 2009, Pages 565-573

  Li, Shizhe ^a   Zhang, Yan ^a   Wang, Shumin ^b   Yang, Jehoon ^a   Araneta, Maria Ferraris ^a   Farris, Amanda ^a   Johnson, Christopher ^a   Fox, Stephen ^c   Innis, Robert ^a   Shen, Jun ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Decoupling; Human brain; In vivo 13C MRS

Indexed keywords

AMINO ACIDS; FINITE DIFFERENCE TIME DOMAIN METHOD; GLUCOSE; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; PLANTS (BOTANY); SCANNING; STOCHASTIC SYSTEMS; TIME DOMAIN ANALYSIS;

BROAD FREQUENCY RANGE; DECOUPLING; FINITE DIFFERENCE TIME DOMAINS; GAMMA-AMINOBUTYRIC ACIDS; HUMAN BRAIN; IN-VIVO; SPECIFIC ABSORPTION RATE; SPECTRAL INTERFERENCE;

BRAIN;

4 AMINOBUTYRIC ACID; ALKANE; AMIDE; ASPARTIC ACID; CARBON; CARBON 13; CARBOXYLIC ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; LIPID; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; COMPUTER; CONTROLLED STUDY; CROSS COUPLING REACTION; FREQUENCY MODULATION; GLUCOSE ABSORPTION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INFUSION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; POWER SUPPLY; SIGNAL DETECTION; SIGNAL PROCESSING; STOCHASTIC MODEL; ALGORITHM; COMPUTER SYSTEM; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STATISTICS; TISSUE DISTRIBUTION;

ALGORITHMS; BRAIN; CARBON ISOTOPES; COMPUTER SYSTEMS; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; STOCHASTIC PROCESSES; TISSUE DISTRIBUTION;

EID: 68249087001     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22044     Document Type: Article

References (49)

1. 13C NMR for the assessment of human brain glucose metabolism in vivo. Biochemistry 1991;30:6362-6366.
2. 13C]glucose. J Neurochem 1994;63:1377-1385.
3. Mason GF, Gruetter R, Rothmann DL, Behar KL, Shulman RG, Novotny EJ. Simultaneous determination of the rates of the TCA cycle, glucose utilization, α-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 1995;15:12-25.
4. 13C MRS of the human brain at 4 Tesla. Magn Reson Med 1996;36:659-664.
5. 13C-NMR of glutamate metabolism in the human brain: initial results at 4 Tesla. Dev Neurosci 1998;20:380-388.
6. 13C NMR. Proc Natl Acad Sci U S A 1999;96:8235-8240.
7. Pan JW, Stein DT, Telang F, Lee JH, Shen J, Brown P, Cline G, Mason GF Shulman GI, Rothman DL, Hetherington HP. Spectroscopic imaging of glutamate C4 turnover in human brain. Magn Reson Med 2000;44:673-679. (Pubitemid 30819778)
8. Bluml S, Moreno A, Hwang JH, Ross BD. 1-13C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed 2001;14:19-32. (Pubitemid 32273267)
9. 13C MRS examinations of the brain. Magn Reson Med 2001;46:39-48.
10. Shulman RG, Rothman DL. Brain energetics and neuronal activity. Chichester, UK: John Wiley & Sons; 2004.
11. 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci 2002;22:1523-1531.
12. Bluml S, Moreno-Torres A, Shic F, Nguy CH, Ross BD. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed 2002;15:1-5. (Pubitemid 34177162)
13. 13C]glucose. Brain Res Protoc 2003;10:181-190.
14. 13C]glucose. J Neurochem 2007;100:73-86.
15. 13C MRS at 1.5T: clinical applications to dietary therapy. NMR Biomed 2003;16:160-167.
16. 13C magnetic resonance spectroscopy study. MAGMA 2003;16:29-42.
17. 13C-magnetic resonance spectroscopy observation in the human brain. NeuroReport 2005;16:2057-2060.
18. Criteria for significant risk investigations of magnetic resonance diagnostic devices. Center for Devices and Radiological Health, Food and Drug Administration, USA; 2003. http://www.fda.gov/cdrh/ode/guidance/793.html
19. International Electrotechnical Commission. International standard, medical equipment - part 2: particular requirements for the safety of magnetic resonance equipment for medical diagnosis, 2nd revision. Geneva: International Electrotechnical Commission 2002;601:2-33.
20. Adriany G, Gruetter R. A half-volume coil for efficient proton decoupling in human at 4 Tesla. J Magn Reson 1997;125:178-184. (Pubitemid 127451368)
21. Shellock FG, Crues JV. Corneal temperature changes induced by high-field-strength MR imaging with a head coil. Radiology 1988;167:809-811. (Pubitemid 18130734)
22. Shellock FG, Schatz CJ. Increased corneal temperature caused by MR imaging of the eye with a dedicated local coil. Radiology 1992;185:697-699.
23. Elder JA. Ocular effects of radiofrequency energy. Bioelectomagnetics 2003;6:S148-S161.
24. Barker PB, Golay X, Artemov D, Ouwerkerk R, Smith MA, Shaka AJ. Broadband proton decoupling for in vivo brain spectroscopy in humans. Magn Reson Med 2001;45;226-232. (Pubitemid 32119006)
25. 13C MR spectroscopy of the human brain at 3 Tesla. Magn Reson Med 2006;55:271-278.
26. Klomp DWJ, Kentgens APM, Heerschap A. Polarization transfer for sensitivity-enhanced MRS using a single radio frequency transmit channel. NMR Biomed 2008;21:444-452. (Pubitemid 351895432)
27. 13C MRS using very low RF power for proton decoupling. Magn Reson Med 2007;57:265-271.
28. 13C MRS using low RF power for proton decoupling on a 3 Tesla clinical scanner. In: Proc 15th Annual Meeting ISMRM, Berlin; 2007. p 535.
29. 13C]glucose infusion. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008. p 1560.
30. 13C MRS for neuropsychiatric disorders of the frontal lobe. J Magn Reson 2008;195:219-225.
31. Bottomley PA, Hardy CJ, Roemer PB, Mueller OM. Proton-decoupled, Overhauser-enhanced, spatially localized carbon-13 spectroscopy in humans. Magn Reson Med 1989;12:348-363.
32. Saito M, Matsuda T, Tropp J, Inubushi T, Nakai T. Assessment of the specific absorption rate and calibration of decoupling parameters for proton decoupled carbon-13 MR spectroscopy at 3.0 T. Eur J Radiol 2005;55:289-293. (Pubitemid 40982451)
33. Ernst RR. Nuclear magnetic double resonance with an incoherent radio-frequency field. J Chem Phys 1966;45:3845-3861.
34. Gabriel C. Compilation of the dielectric properties of body tissues at RF and microwave frequencies. Technical Report, Brooks Air Force AL/OE-TR-1996-10037
35. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993;29:804-811. (Pubitemid 23182863)
36. 15N heteronuclear multiple-quantum coherence-transfer NMR in severely hyperammonemic rat. J Neurochem 1997;18:1209-2119.
37. 13C NMR of brain. Magn Reson Med 1985;2:289-295.
38. 13C NMR spectroscopy. NMR Biomed 1993;6:264-277.
39. Fan TWM. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nuclear Magn Reson Spectrosc 1996;28:161-219.
40. 13C NMR spectra using LCModel. NMR Biomed 2003;16:400-412.
41. 13C NMR. In: Proc 8th Annual Meeting ISMRM, Denver; 2000. p 422.
42. 13C MRS in vivo. NMR Biomed 2003;16:358-369.
43. 13C MR spectra acquired from human brain in vivo. J Magn Reson 2003;162:259-268.
44. 13C MRS of rhesus monkey brain. NMR Biomed 2005;18:560-569.
45. Ordidge RJ. Random noise selective excitation pulses. Magn Reson Med 1987;5:93-98.
46. Choi IY, Tkac I, Gruetter R. Single-shot, three-dimensional "non-echo" localization method for in vivo NMR spectroscopy. Magn Reson Med 2000;44:387-394.
47. 13C magnetic resonance spectroscopy. J Neurosci Res. 2001;66:737-746.
48. 1H decoupling. Magn Reson Med 2006;55:279-286.
49. 13C spectroscopy at 3 T in human frontal lobe: SAR analysis using numerical simulation. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008. p 783.